
Fred Hutch / University of Washington / Seattle Children’s Cancer ...
2025年3月24日 · Learn about research programs and scientific initiatives at Fred Hutch/University of Washington Cancer Consortium, an NCI-Designated Comprehensive Cancer Center.
Fred Hutch / University of Washington / Seattle Children’s Cancer ...
The Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium is a collaboration among three partner institutions: the Fred Hutchinson Cancer Center, the University of Washington, and Seattle Children’s Hospital.
Find an NCI-Designated Cancer Center - NCI - National Cancer …
Find the locations of NCI-designated cancer centers by area, region, state, or name that includes contact information to help health care providers and cancer patients with referrals to clinical trials.
A Multilevel Intervention to Increase Colorectal Cancer Screening …
This clinical trial studies whether an intervention that addresses two or more levels of care (multilevel intervention) increases follow-up of abnormal, non-invasive, colorectal cancer (CRC) screening test results.
Contact NCI - NCI - National Cancer Institute
Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions whether you are a patient, family member or friend, health care provider, or researcher. Our service is available in English and Spanish.
ST-067 and Teclistamab for the Treatment of Relapsed or …
Inclusion Criteria. Multiple myeloma, as defined by the presence of at least one International Myeloma Working Group (IMWG) MM-defining event; Measurable disease as defined by IMWG criteria, requiring one or more of the following: * Serum M-protein ≥ 0.5 g/dL * Urine M-protein ≥ 200 mg/24h * Involved serum free light chain ratio ≥ 10 mg/dL with abnormal kappa/lambda …
CCSG Leadership | Office of Cancer Centers
2024年6月5日 · ComponentType Institution Name Leader Title; Admin: Albert Einstein College of Medicine: Lauren Hackett, MPA: Deputy Director for Administration: Admin
Dose Escalation and Expansion of BBO-10203 in Advanced Solid …
This is an open-label, multi-center Phase 1a/1b study designed to evaluate the safety, tolerability, preliminary antitumor activity, and PK of BBO-10203 as a single agent and
Clinical Trials Using Treosulfan - NCI - National Cancer Institute
Clinical trials are research studies that involve people. The clinical trials on this list are studying treosulfan. All trials on the list are NCI-supported clinical trials, which are sponsored or otherwise financially supported by NCI.
State Cancer Profiles > Quick Profiles
Notes: Created by statecancerprofiles.cancer.gov on 04/05/2025 8:44 am. For more explicit data source and footnote information please see the tables, graphs and maps that are linked to each row.